Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Surgery alone, adjuvant tegafur/gimeracil/octeracil (S-1), or platinum-based chemotherapies for resectable gastric cancer: real-world experience and a propensity score matching analysis

Fig. 1

Flow diagram of the study. aConcomitant malignancies other than gastric cancer (n=6), metastatic carcinoma not confined to gastric origin (n = 3), and esophageal carcinoma with gastric invasion (n = 2). GC, gastric cancer; GEJC, gastroesophageal junction cancer; NCKUH, National Cheng Kung University Hospital; CCRT, concurrent chemoradiotherapy; LN, lymph node; PPS, propensity score

Back to article page